Hospital Mater Dei SA
BOVESPA:MATD3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hospital Mater Dei SA
BOVESPA:MATD3
|
BR |
|
S
|
Safran SA
SWB:SEJ1
|
FR |
|
L
|
Linamar Corp
XBER:LNR
|
CA |
|
Sanki Engineering Co Ltd
TSE:1961
|
JP |
|
Wuhan Guide Infrared Co Ltd
SZSE:002414
|
CN |
|
Shouhui Group Ltd
HKEX:2621
|
CN |
|
Intsig Information Co Ltd
SSE:688615
|
CN |
|
Prairiesky Royalty Ltd
TSX:PSK
|
CA |
|
Hundsun Technologies Inc
SSE:600570
|
CN |
|
E
|
Ethos Ltd
NSE:ETHOSLTD
|
IN |
|
C
|
Creative & Innovative System Corp
KOSDAQ:222080
|
KR |
|
Fit Corp
TSE:1436
|
JP |
|
Saudi Cable Company SJSC
SAU:2110
|
SA |
Wall St Price Targets
MATD3 Price Targets Summary
Hospital Mater Dei SA
According to Wall Street analysts, the average 1-year price target for MATD3 is 6.9 BRL with a low forecast of 6.36 BRL and a high forecast of 7.35 BRL.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MATD3's stock price target?
Price Target
6.9
BRL
According to Wall Street analysts, the average 1-year price target for MATD3 is 6.9 BRL with a low forecast of 6.36 BRL and a high forecast of 7.35 BRL.
What is the Revenue forecast for Hospital Mater Dei SA?
Projected CAGR
6%
Over the last 6 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Hospital Mater Dei SA?
Projected CAGR
9%
Over the last 6 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 4 years is 9%.
What is the Net Income forecast for Hospital Mater Dei SA?
Projected CAGR
20%
Over the last 6 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 8 years is 20%.
